Waters Corp has featured in a range of news entailing both achievements and discoveries, challenging business scenarios, and strategic investments. Among the key developments, the company has made strides in accelerating the development of
gene-based therapeutics using its GTxResolve Premier SEC Columns. It announced seamless integration of
HPLC/UPLC data bridge for light scattering, marking a significant milestone. Besides, Waters Corporation launched the
ACQUITY QDa II Mass Detector, promising to deliver a wider range of chemical analysis. On a similar note,
rapid-screening DSC was launched to enable faster thermal stability testing.
In the business operations realm, however, Waters Corp displayed some fluctuations. While Q1 2024 earnings aligned with EPS projections despite sales decline, Q2 earnings were reported above the estimates. It also reported reduced demand as a cause for a lower profit forecast.
Significantly, there’s a business unit leadership transition in progress, and the company appoints new members to its Board of Directors. Waters Corp demonstrated commitment towards sustainability, earning a
sustainability designation from My Green Lab, and it was acknowledged by Human Rights Campaign Foundation's corporate equality index.
The company's stock performance presented varied analysis as analysts raised price targets following an earnings report, but it still underperformed on some days. Other highlight include strategic investments from companies such as Investment Advisory Group LLC and Kintegral Advisory LLC.
Waters Corp WAT News Analytics from Wed, 29 Jul 2015 17:43:15 GMT to Fri, 06 Sep 2024 21:11:00 GMT -
Rating 1
- Innovation 8
- Information 6
- Rumor -1
